跳至主要内容
临床试验/ISRCTN30703970
ISRCTN30703970已完成2 期

Oral thiamine (Vitamin B1) supplementation in subjects with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled crossover trial assessing biophysical markers of endothelial function, oxidant stress, insulin sensitivity and vascular inflammation

Portsmouth Hospitals NHS Trust (UK)0 个研究点目标入组 34 人开始时间: 2010年1月4日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Individuals with a diagnosis of type 2 diabetes mellitus with a more than 30% chance of cardiovascular disease (ischaemic heart disease, cerebrovascular disease or peripheral vascular disease) over the next 10 years
  • 2. HbA1c less than 10%
  • 3. Between the ages of 18 and 75 years, either sex

排除标准

  • 1. Established cardiovascular disease (ischaemic heart disease, cerebrovascular disease or peripheral vascular disease)
  • 2. Allergy/intolerance to thiamine supplementation
  • 3. Insulin treatment
  • 4. Diuretic treatment
  • 5. Current multivitamin/thiamine therapy
  • 6. Abnormal thyroid function
  • 7. Chronic excess alcohol consumption/impaired liver function (greater than 21 units per week in females, greater than 28 units per week in males; Department of Health Guidelines)

研究者

发起方
Portsmouth Hospitals NHS Trust (UK)

相似试验

进行中(未招募)
不适用
Oral thiamine (Vitamin B1) supplementation in subjects with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled crossover trial assessing biophysical markers of endothelial function, oxidant stress, insulin sensitivity and vascular inflammation - Thiamine supplementation in type 2 diabetes.Type 2 diabetes
EUCTR2009-017537-21-GBPortsmouth Hospitals NHS Trust34
已完成
2 期
Vitamin B1 (thiamine) administration in enterally-fed critically ill patients with hypophosphatemia: A prospective, randomised clinical trialHypophosphatemiaCritical illnessenteral nutritionMetabolic and Endocrine - Other metabolic disordersDiet and Nutrition - Other diet and nutrition disordersThiamine deficiency
ACTRN12619000121167Royal Melbourne Hospital90
招募中
3 期
The protective effect of Thiamine (vitamin B1) for Bortezomib induced peripheral neuropathy in multiple myelomaneuropathy.
IRCT20190116042379N1Esfahan University of Medical Sciences58
进行中(未招募)
不适用
Preoperative parenteral thiamine supplementation in patients undergoing heart surgeryThe objective of this study is to determine the prevalence of thiamine deficiency (TD) in patients with heart surgery, to examine the association between thiamine levels and lactic acidosis and to prevent the increase of lactate by vitamin B1 supplementation.
EUCTR2011-004080-70-ATMed. Univ. Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie100
已完成
Unknown
Investigating the effect of vitamin B1 oral tablets on the post covid-19 syndromePost covid-19 syndrome.COVID-19, virus identifiedU07.1
IRCT20221229056979N1Shahid Beheshti University of Medical Sciences60